Literature DB >> 19214661

Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease.

Takeshi Kamiya1, Hiroshi Adachi, Makoto Hirako, Michiko Shikano, Eriko Matsuhisa, Tsuneya Wada, Naotaka Ogasawara, Shunsuke Nojiri, Hiromi Kataoka, Makoto Sasaki, Hirotaka Ohara, Takashi Joh.   

Abstract

BACKGROUND: More than half of patients with refluxrelated symptoms have no endoscopic evidence of mucosal breaks. These patients are considered to have nonerosive gastroesophageal reflux disease (NERD). The pathogenesis of NERD may be multifactorial, but the role played by gastric motility in symptom generation in patients with NERD has not been examined. In this study, we elucidate gastric motility in patients with NERD and the efficacy of a prokinetic agent in the treatment of NERD.
METHODS: Gastric motility was evaluated with electrogastrography (EGG) and by measurement of gastric emptying using the acetaminophen method in 26 patients with NERD and in 11 matched healthy controls. NERD patients were treated with a prokinetic agent (mosapride 15 mg, orally three times daily) for a period of 4 weeks, after which gastric motility was measured again.
RESULTS: Compared with the healthy controls, the NERD patients showed a significantly lower percentage of normogastria, a lower power ratio in EGG, and delayed gastric emptying. Ten patients had normal gastric motor function (group A), and 16 showed abnormalities of either gastric myoelectrical activity or gastric emptying (group B). After treatment with mosapride, gastric motility improved significantly in both groups of patients compared with pretreatment values. The subjective assessment by the patient after the treatment was improved in 20.0% of group A versus 62.5% of group B patients (P < 0.05).
CONCLUSIONS: Gastric hypomotility appears to be an important factor in reflux symptom generation in some NERD patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214661     DOI: 10.1007/s00535-008-2289-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  40 in total

1.  Effect of meal and intravenous erythromycin on manometric and electrogastrographic measurements of gastric motor and electrical activity.

Authors:  C Faure; V P Wolff; J Navarro
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

2.  AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.

Authors:  N Yoshida; T Ito; T Karasawa; Z Itoh
Journal:  J Pharmacol Exp Ther       Date:  1991-05       Impact factor: 4.030

3.  Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

Authors:  J P Galmiche; P Barthelemy; B Hamelin
Journal:  Aliment Pharmacol Ther       Date:  1997-08       Impact factor: 8.171

4.  Electrogastrographic study of gastric myoelectrical activity in patients with unexplained nausea and vomiting.

Authors:  H Geldof; E J van der Schee; M van Blankenstein; J L Grashuis
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

5.  Gastric electrical dysrhythmias and delayed gastric emptying in gastroesophageal reflux disease.

Authors:  S Cucchiara; G Salvia; O Borrelli; E Ciccimarra; N Az-Zeqeh; S Rapagiolo; R Minella; A Campanozzi; G Riezzo
Journal:  Am J Gastroenterol       Date:  1997-07       Impact factor: 10.864

6.  Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy.

Authors:  A A Masclee; A C de Best; R de Graaf; O J Cluysenaer; J B Jansen
Journal:  Scand J Gastroenterol       Date:  1990-03       Impact factor: 2.423

7.  Heartburn--the acid test.

Authors:  B Joelsson; F Johnsson
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

8.  The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.

Authors:  R Carlsson; J Dent; E Bolling-Sternevald; F Johnsson; O Junghard; K Lauritsen; S Riley; L Lundell
Journal:  Scand J Gastroenterol       Date:  1998-10       Impact factor: 2.423

9.  Gastric emptying in patients with gastroesophageal reflux.

Authors:  R W McCallum; D M Berkowitz; E Lerner
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

10.  Identification of gastric contractions from the cutaneous electrogastrogram.

Authors:  J D Chen; R D Richards; R W McCallum
Journal:  Am J Gastroenterol       Date:  1994-01       Impact factor: 10.864

View more
  13 in total

Review 1.  Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review.

Authors:  Qing Liu; Chen-Chen Feng; Er-Man Wang; Xiu-Juan Yan; Sheng-Liang Chen
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

2.  Mosapride citrate improves postoperative ileus of patients with colectomy.

Authors:  Yoshitaka Toyomasu; Erito Mochiki; Hiroki Morita; Atsushi Ogawa; Mitsuhiro Yanai; Tetsuro Ohno; Takaaki Fujii; Soichi Tsutsumi; Takayuki Asao; Hiroyuki Kuwano
Journal:  J Gastrointest Surg       Date:  2011-05-24       Impact factor: 3.452

3.  Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan.

Authors:  Kazunari Tominaga; Ryuichi Iwakiri; Kazuma Fujimoto; Yasuhiro Fujiwara; Mio Tanaka; Yasuyuki Shimoyama; Eiji Umegaki; Kazuhide Higuchi; Motoyasu Kusano; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2011-11-15       Impact factor: 7.527

4.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

5.  Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia.

Authors:  Hyun Chul Lim; Sang In Lee; Jiande D Z Chen; Hyojin Park
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

Review 6.  Gastric dysrhythmia in gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Sameer Bhat; Chris Varghese; Daniel A Carson; Tommy C L Hayes; Armen A Gharibans; Christopher N Andrews; Gregory O'Grady
Journal:  Esophagus       Date:  2021-02-16       Impact factor: 4.230

Review 7.  Electrogastrography in adults and children: the strength, pitfalls, and clinical significance of the cutaneous recording of the gastric electrical activity.

Authors:  Giuseppe Riezzo; Francesco Russo; Flavia Indrio
Journal:  Biomed Res Int       Date:  2013-05-25       Impact factor: 3.411

8.  Diabetes and risk of cancer.

Authors:  Samy L Habib; Maciej Rojna
Journal:  ISRN Oncol       Date:  2013-02-07

9.  Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study.

Authors:  Hyun Chul Lim; Jie-Hyun Kim; Young Hoon Youn; Eun Hee Lee; Byung Keon Lee; Hyojin Park
Journal:  J Neurogastroenterol Motil       Date:  2013-10-07       Impact factor: 4.924

10.  Association between Minimal Change Esophagitis and Gastric Dysmotility: A Single-Center Electrogastrography and Endoscopy Study in Children.

Authors:  Kyung In Lim; Sung Bo Shim; Hann Tchah; Eell Ryoo
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.